Search results
Swiss biotech ecosystem recuperates from global financial instability
Pharmaceutical Technology via Yahoo Finance· 4 days agoAs the country where pharma giants like Novartis and Roche first started, Switzerland has long been...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg via Yahoo Finance· 5 days ago...Inc.Most Read from BloombergWorld’s Largest Nuclear Plant Sits Idle While Energy Needs Soar‘Not...
Is Semaglutide the
Medscape· 1 day agoThere has been much hyperbole since the presentation of results from the SELECT cardiovascular outcomes trial (CVOT) at this year's European Congress on...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 2 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
Tenecteplase Beneficial in Late LVO Stroke Except EVT Access
Medscape· 6 days agoTenecteplase improved functional outcome in patients with LVO presenting beyond 4.5 hours who had...
‘I’m a stuntman with no pension – should I sell four of my Lamborghinis and buy gold?’
The Telegraph via Yahoo Finance· 3 days agoWith the equity allocation, he could allocate around 70pc to overseas stocks and shares with a bias...
Carefully Designing De-escalation Trials in Breast Cancer
Medscape· 5 days agoDe-escalation trials in early breast cancer are "critical to preserving quality of life" but require...
Is Your Intellectual Property Safe With Indian CROs And CDMOs?
BioresearchOnline· 1 day agoPlease note: This is not a legal document, although I have included input from attorneys based in...
Improved Outcomes With Subcutaneous Amivantamab in NSCLC
Medscape· 2 days agoSubcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 2 days agoEGFR testing now needed for all patients with stage III disease, experts say